mRNA |
NVP-BSK805 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
1e-08 |
mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
4e-08 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
4e-08 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
8e-08 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
2e-07 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
5e-06 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
7e-06 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
7e-06 |
mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
7e-06 |
mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
9e-06 |